Please assess the completion status of the following clinical trial:

Trial Title: Robotic Training for Stroke Neurorehabilitation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 21 or older~* Ischemic or hemorrhagic stroke (with confirmatory neuroimaging) that occurred more than 6 months before entering the study~* Presence of voluntary hand activity indicated by a score of at least 1 on the finger mass extension/grasp release item of the Fugl-Meyer Test of Motor Function~* Adequate cognitive status, as determined by clinical evaluation~* No upper extremity injury or conditions that limited use prior to the stroke~Exclusion Criteria:~* Cannot give informed consent~* Have clinically significant fluctuations in mental status within a month of enrollment~* Were not independent prior to the stroke as measured by scores \<95 on the Barthel Index or \>1 on the Modified Rankin Scale~* Have hemispatial neglect as determined by \>3 errors on the Star Cancellation Test~* Have severe sensory loss as determined by a score of 2 on the sensory item of the NIHSS~* Receiving oral or injected antispasticity medications during study treatment~* Pain that interferes with daily activities~* History of prior stroke

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Robotic (Type: EXPERIMENTAL): The experimental group will receive 1-hour robotic training sessions, 3 times per week for a total of 12 sessions supervised by a research assistant. Immediately following this robot training, these subjects will receive the same dosage and schedule (1-hour sessions, 3 times/week, 12 total sessions) of conventional one-on-one therapy from an occupational therapist.
- Conventional (Type: ACTIVE_COMPARATOR): Subjects will receive 24 hours of one-on-one treatment from an occupational therapist. The treatment schedule will parallel that given to the experimental group (1-hour sessions, 3 times/week).

Based on this trial design, predict the completion outcome and termination type (if applicable).